82671-03-2

Usage

Uses

Used in Pharmaceutical Industry:
Ethyl 2,6-dichloro-5-fluoropyridine-3-carboxylate is used as an intermediate in the synthesis of various pharmaceutical compounds for its unique molecular structure and functional groups. It can be utilized in the development of new drugs, particularly those targeting specific biological pathways or receptors.
Used in Chemical Industry:
Ethyl 2,6-dichloro-5-fluoropyridine-3-carboxylate is used as a building block or reagent in the synthesis of other organic compounds, taking advantage of its reactive functional groups and the potential for further chemical modifications. It can contribute to the creation of specialty chemicals, agrochemicals, or materials with specific properties.
Used in Research and Development:
Ethyl 2,6-dichloro-5-fluoropyridine-3-carboxylate is used as a research compound to explore its chemical properties, reactivity, and potential applications in various fields. It can serve as a starting material for the development of new synthetic methods, catalysts, or as a probe in mechanistic studies.

InChI:InChI=1/C8H6Cl2FNO2/c1-2-14-8(13)4-3-5(11)7(10)12-6(4)9/h3H,2H2,1H3

Upstream product

• 541-41-3 chloroformic acid ethyl ester 
• 82671-06-5 2,6-dichloro-5-fluoro-3-pyridinecarboxylic acid 
• 64-17-5 ethanol 

Downstream Products

• 82671-06-5 2,6-dichloro-5-fluoro-3-pyridinecarboxylic acid 
• 151322-65-5 ethyl 2-chloro-5-fluoro-6-(methylthio)pyridine-3-carboxylate 
• 917835-69-9 (5-fluoro-6-methylpyridin-3-yl)methanol 
• 100492-04-4 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid 
• 1420366-78-4 ethyl 6-(3,4-difluorophenoxy)-5-fluoronicotinate 
• 1420366-74-0 ethyl 2-chloro-6-(3,4-difluorophenoxy)-5-fluoronicotinate 
• 1039068-11-5 ethyl 6-{4-[(benzylsulfonyl)carbamoyl]piperidin-1-yl}-2-chloro-5-fluoronicotinate 
• 1035217-05-0 ethyl 2-chloro-6-({(1R)-1-[(cyclohexylmethyl)carbamoyl]-2-methylpropyl}amino)-5-fluoronicotinate 
• 114171-67-4 1-Cyclopropyl-4-oxo-6-piperidin-1-yl-7-(toluene-4-sulfonyl)-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid ethyl ester 
• 96568-27-3 ethyl 2-amino-5-fluoro-6-(p-tolylthio)nicotinate 
• 96568-30-8 ethyl 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(p-tolylsulfonyl)-1,8-naphthyridine-3-carboxylate 
• 114171-71-0 ethyl 1-cyclopropyl-6-fluoro-1,2-dihydro-4-hydroxy-7-(p-tolylthio)-1,8-naphthyridine-3-carboxylate 
• 114171-61-8 ethyl 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(p-tolylsulfinyl)-1,8-naphthyridine-3-carboxylate 
• 96568-29-5 ethyl 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(p-tolylthio)-1,8-naphthyridine-3-carboxylate 

Relevant academic research and scientific papers

SUBSTITUTED OXAZOLE- AND THIAZOLE-BASED CARBOXAMIDE AND UREA DERIVATIVES AS VANILLOID RECEPTOR LIGANDS II

The invention relates to oxazole and thiazole-based carboxamide and urea derivatives as vanilloid receptor ligands, to pharmaceutical compositions containing these compounds and also to these compounds for use in the treatment and/or prophylaxis of pain and further diseases and/or disorders.

HETEROCYCLIC METHYL SULFONE DERIVATIVE

Provided is a compound capable of inhibiting production or secretion of β amyloid protein. A compound represented by the following formula (1): (wherein, R1 represents a heterocyclic group which may have a substituent, R2 represents a cyclic hydrocarbon group which may have a substituent or a heterocyclic group which may have a substituent, R3 represents a cyclic hydrocarbon group which may have a substituent or a heterocyclic group which may have a substituent, R4 represents a hydrogen atom or a C1-6 alkyl group, and X represents -S-,-SO- or -SO2-) an N-oxide or S-oxide thereof; a salt thereof; or a solvate thereof; and a medicament containing any of them.

Angiotensin II receptor antagonists

Compounds are disclosed having the formula: STR1 The compounds of the invention are angiotensin II receptor antagonists.